Commentary · 21 Feb 2026
Conference abstractPublished 15 Sep 2014
Tumor immune microenvironment in lung cancer: Is it prime time to add immunological prognostic markers to TNM classification?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tumor-associated immune responses have polarized effects in regulating tumor growth. Although a clear association has been shown between the tumor immune response and clinical outcome in colorectal and ovarian cancers, the role of immune markers for stratifying prognosis in non-small cell lung cancer (NSCLC) is less defined. As a first step, our laboratory performed a comprehensive review of the prognostic significance of published immune markers in the tumor microenvironment and peripheral blood of NSCLC patients. To identify prognostic immune genes, we reviewed all published gene-profiling studies in NSCLC and delineated the significance of immune genes by doing subanalysis on the microarray database of the NIH Director's Challenge study from our institution. These results were published (Clinical Cancer Research 2011) and currently highly cited. We then performed extensive analysis of the immune responses in early-stage lung adeno and squamous cell cancers (n=1600). Parts of these results were published in JCO, Journal of Clinical Oncology, 2013. Subsequently, we identified the aggressive morphological subtypes of lung adenocarcinoma associations with specific immunological profile. These combined data provided solid evidence that immunological composition of lung cancers can provide more biological and prognostic information than current TNM staging. We propose that it is time to validate these results from a multi-national cohort and consider incorporating ?immunological score? into current TNM classification for lung cancer. Furthermore, this score will play a greater role in the management of emerging immunotherapies.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Prasad S Adusumilli”
